Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Walsh

Showing results (241-250 of 361) with videos related to

Pageof 37
Sort By:
JAMA|June 19, 2008
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomyBruce J Trock, Misop Han, Stephen J Freedland, et al.
JAMA|July 28, 2005
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomyStephen J Freedland, Elizabeth B Humphreys, Leslie A Mangold, et al.
Journal of the National Cancer Institute|November 6, 2003
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsiesSusan V Harden, Harriette Sanderson, Steven N Goodman, et al.
Journal of the National Cancer Institute|April 19, 2011
Cigarette smoking and prostate cancer recurrence after prostatectomyCorinne E Joshu, Alison M Mondul, Cari L Meinhold, et al.
The Journal of Urology|March 23, 2011
A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomyPhillip M Pierorazio, Ashley E Ross, Edward M Schaeffer, et al.
The Journal of Urology|August 27, 2015
Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?Lori J Sokoll, Zhen Zhang, Daniel W Chan, et al.
The Journal of Urology|May 20, 2009
Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen levelStacy Loeb, H Ballentine Carter, Patrick C Walsh, et al.
BJU International|July 14, 2012
Impact of surgical margin status on prostate-cancer-specific mortalityHeather J Chalfin, Michael Dinizo, Bruce J Trock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortalityStephen J Freedland, Elizabeth B Humphreys, Leslie A Mangold, et al.
The Journal of Urology|August 19, 2007
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomyAhmed Magheli, Soroush Rais-Bahrami, Hugh J Peck, et al.
Pageof 37

Showing results (241-250 of 361) with videos related to

Sort By:
Pageof 37
JAMA|June 19, 2008
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomyBruce J Trock, Misop Han, Stephen J Freedland, et al.
JAMA|July 28, 2005
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomyStephen J Freedland, Elizabeth B Humphreys, Leslie A Mangold, et al.
Journal of the National Cancer Institute|November 6, 2003
Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsiesSusan V Harden, Harriette Sanderson, Steven N Goodman, et al.
Journal of the National Cancer Institute|April 19, 2011
Cigarette smoking and prostate cancer recurrence after prostatectomyCorinne E Joshu, Alison M Mondul, Cari L Meinhold, et al.
The Journal of Urology|March 23, 2011
A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomyPhillip M Pierorazio, Ashley E Ross, Edward M Schaeffer, et al.
The Journal of Urology|August 27, 2015
Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?Lori J Sokoll, Zhen Zhang, Daniel W Chan, et al.
The Journal of Urology|May 20, 2009
Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen levelStacy Loeb, H Ballentine Carter, Patrick C Walsh, et al.
BJU International|July 14, 2012
Impact of surgical margin status on prostate-cancer-specific mortalityHeather J Chalfin, Michael Dinizo, Bruce J Trock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortalityStephen J Freedland, Elizabeth B Humphreys, Leslie A Mangold, et al.
The Journal of Urology|August 19, 2007
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomyAhmed Magheli, Soroush Rais-Bahrami, Hugh J Peck, et al.
Pageof 37